Shilpa Vasishta
Jared E. Coe
Daniel A. Burack
Helen Tsai
Emily H. Miller
Margaret E. McCort
Inessa Gendlina
<p>Despite tremendous progress, exact mechanism of hospital transmission of infections remans uncertain. My research interest lies in understanding mechanism of transmisison of <em>Clostridioides difficile</em> in acute care setting. Specifically, I would like to understand spatio-temporal factors involved in <em>Clostridioides difficile</em> acquisition and transmission, and apply process improvement methodology to limit HAI trasnmission. I am also interested in leveraging EMR data and healthcare informatics tools to improve early recognition and management of sepsis. </p>
<p>My clinical infectious diseases interest lies is preventing, treating and managing infections with patients with immune-mediated inflammatory disease (IMID), including patients with primary and secondary immunedeficiencies as well as drug induced immune dysregulation. </p>
<p> </p>
<p style="font-family: Calibri; font-size: medium;">Gendlina I, Held KG, Bartra SS, Gallis BM, Doneanu CE, Goodlett DR, Plano GV, Collins CM. Identification and type III-dependent secretion of the Yersinia pestis insecticidal-like proteins. Mol Microbiol. 2007 Jun;64(5):1214-27. PubMed PMID: 17542916.</p>
<p style="font-family: Calibri; font-size: medium;">Gendlina I. Identification and Characterization of a Yersinia pestis insecticidal-like toxin complex. Miami: University of Miami; 2006. 229p</p>
<p style="font-family: Calibri; font-size: medium;">Gendlina I, Gutman DM, Thomas V, Collins CM. Urea-dependent signal transduction by the virulence regulator UreR. J Biol Chem. 2002 Oct 4;277(40):37349-58. PubMed PMID: 12147687.</p>
<p style="font-family: Calibri; font-size: medium;">Ames RY, Ting LM, Gendlina I, Kim K, Macian F. The Transcription Factor NFAT1 Participates in the Induction of CD4<sup>+</sup> T Cell Functional Exhaustion during Plasmodium yoelii Infection. Infect Immun. 2017 Sep;85(9)PubMed PMID: 28630062; PubMed Central PMCID: PMC5563568.</p>
<p style="font-family: Calibri; font-size: medium;">Gendlina I, Silmon de Monerri N, Kim K. Modification of the Host Epigenome by Parasitic Protists. Springer series on Epigenetics and Human Health. 2017</p>
Barry S. Zingman
<p>Barry S. Zingman, M.D., has been the Medical Director of the AIDS Center at Montefiore since 2003 following his service as Medical Director of the AIDS Center's Center for Positive Living/Infectious Diseases (CPL/ID) Clinic for five years.</p>
<p>Dr. Zingman directs the largest multidisciplinary and multispecialty adult HIV/AIDS treatment and prevention program in New York State. His program’s clinical sites include (1) the Center for Positive Living/I.D. Clinic, for HIV, Hepatitis C, and general Infectious Diseases care; (2) The Oval Center at Montefiore, which provides screening and treatment for sexually transmitted infections, HIV pre- and post-exposure prophylaxis programs, and Hepatitis C care; and (3) other inpatient and outpatient sites at the Moses Division of Montefiore Medical Center. He has been Principal Investigator or Medical Director on over 75 HIV/AIDS-related research protocols and grants. These currently include grants from HRSA, the New York State Department of Health's AIDS Institute, NIH, and industry for multidisciplinary HIV primary care and testing; HIV retention, adherence and viral suppression; studies of broadly-neutralizing therapeutic HIV antibodies; new HIV viral load assays; response to pneumococcal vaccine in HIV+ and HIV- individuals; and studies of other new antiretroviral agents.</p>
<p>Dr. Zingman directs an HIV research team consisting of 6 study coordinators that enrolls over 200 patients per year into research protocols.</p>
<p>Dr. Zingman is Professor of Clinical Medicine at Albert Einstein College of Medicine. He is formerly Chair of the AIDS Institute's Medical Care Criteria Committee (the principal body setting HIV care guidelines in NYS); former Vice-Chair of the NYS AIDS Institute's Quality of Care Advisory Committee; and Chair or Member on numerous other state and national HIV quality and standard of care subcommittees. He is a practicing infectious diseases subspecialist and maintains an active patient panel in the CPL/ID Clinic and the Department of Medicine Faculty Practice.</p>
<p> Dr. Zingman directs the largest multidisciplinary and multispecialty adult HIV/AIDS treatment and prevention program in New York State. His program’s clinical sites include (1) the Center for Positive Living/I.D. Clinic, for HIV, Hepatitis C, and general Infectious Diseases care; (2) The Oval Center at Montefiore, which provides screening and treatment for sexually transmitted infections, HIV pre- and post-exposure prophylaxis programs and Hepatitis C care; and (3) other inpatient and outpatient sites at the Moses Division of Montefiore Medical Center. He has been Principal Investigator or Medical Director on over 75 HIV/AIDS-related research protocols and grants. These currently include grants from HRSA, the New York State Department of Health's AIDS Institute, NIH, and industry for multidisciplinary HIV primary care and testing; HIV retention, adherence and viral suppression; studies of broadly-neutralizing therapeutic HIV antibodies; new HIV viral load assays; response to pneumococcal vaccine in HIV+ and HIV- individuals; and studies of other new antiretroviral agents.</p>
<p>Barry S. Zingman, MD, is Medical Director, AIDS Center and Clinical Director, Infectious Diseases at Montefiore Einstein, and Professor, Medicine at our Albert Einstein College of Medicine. Dr. Zingman cares for people with a wide range of infectious disease conditions including HIV care, HIV prevention (PrEP; PEP), sexually transmitted infections, COVID, MPOX (monkeypox), other viral infections, diabetic foot infections, bone infections, heart and lung infections, post-surgical infections, tuberculosis and many others.</p><p>After completing his Bachelor of Arts in biochemistry at Brandeis University in 1981, Dr. Zingman attended New York University School of Medicine, earning his Doctor of Medicine in 1985. He completed his internship and residency in internal medicine at Boston City Hospital in 1988. Dr. Zingman continued his training at Boston University School of Medicine, completing clinical and research fellowships in infectious diseases in 1991.</p><p>Dr. Zingman’s research focuses on new treatments, vaccines, and other preventive strategies for infectious diseases including HIV, sexually transmitted infections, other viral infections, E coli urinary tract infections and others. He has shared his work through peer-reviewed journals, articles, case reports, book chapters, abstracts, and other media as well as presentations, invited lectures and webinars.</p><p>Dr. Zingman is board certified in Infectious Diseases and Internal Medicine. He is a member of the Infectious Disease Society of America (IDSA) and the HIV Medicine Association of IDSA. In 2017, he was inducted into the Leo M. Davidoff Society for distinguished, caring and committed teaching of medical students.</p>
Hyun Ah Yoon
<div id="cit_full" class="meta">
<p class="j"> </p>
</div>
<div class="ab"> </div>